Company intelligence / Profile preview

Wellday

Ownership: Private
Development stage: Commercial

Overview

Wellday offers a gut health product that combines probiotics, parabiotics (heat-killed bacteria), postbiotics, and prebiotics. The product is positioned as a dietary supplement to support digestive and overall gut health. No clinical trial results are referenced.

Therapeutic areas: Gastroenterology
Modalities: ProbioticsParabioticsPostbioticsPrebiotics
Industry: Food & Nutrition

Beyond the preview

Go deeper on Wellday.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Wellday.

Explore the full profile